Colombia INVIMA registration INVIMA 2021RD-0006964

SARS-COV-2 NEUTRALIZATION AB (ECLIA)

Name: SARS-COV-2 NEUTRALIZATION AB (ECLIA) — Colombia INVIMA registration INVIMA 2021RD-0006964
Creator: SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.
Keywords: SARS-COV-2 NEUTRALIZATION AB (ECLIA), INVIMA 2021RD-0006964, III, INVIMA registration

SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTDIIIColombia INVIMAExpires July 16, 2026

VerifiedINVIMA · official registry

Device classification

Registered product (Spanish): SARS-COV-2 NEUTRALIZATION AB (ECLIA)
Risk class / Clase de riesgo: III
Product group (Spanish): REACTIVO DIAGNOSTICO

Registration information

Sanitary registration: INVIMA 2021RD-0006964
Expediente: 20201414
Status / Estado: En tramite renov
Expiry date: July 16, 2026

Registration holder / Titular

Name: SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.

Associated party / Rol

Name: SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD
Role: FABRICANTE
Country: CHINA
Manufacturer: SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD

About this record

Access comprehensive regulatory information for SARS-COV-2 NEUTRALIZATION AB (ECLIA) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA sanitary registration INVIMA 2021RD-0006964, held by SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD. and associated with SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD (FABRICANTE). The registration expires on July 16, 2026.

This page provides complete registration details including product group (REACTIVO DIAGNOSTICO), holder and associated-party information, and regulatory data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.